alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO. WR-45,466-03

EX PARTE COREY DESHUN FARROW, Applicant

ON APPLICATION FOR A WRIT OF HABEAS CORPUS

CAUSE NO. 1280572-B IN THE 180TH DISTRICT COURT

FROM HARRIS COUNTY

Per curiam.

O R D E R

Pursuant to the provisions of Article 11.07 of the Texas Code of Criminal Procedure, the

clerk of the trial court transmitted to this Court this application for a writ of habeas corpus. Ex parte

Young, 418 S.W.2d 824, 826 (Tex. Crim. App. 1967). Applicant was convicted of aggravated sexual

assault and sentenced to forty years’ imprisonment. The Fourteenth Court of Appeals affirmed his

conviction. Farrow v. State, No. 14-11-00449-CR (Tex. App.—Houston [14th Dist.] Dec. 4, 2012)

(not designated for publication).

Applicant contends that he is actually innocent, trial counsel was ineffective, and the State

engaged in misconduct. The trial court entered a timely order designating issues and then entered an

order directing the district clerk to forward the habeas record to this Court. It is not clear, however,
2

whether the trial court made findings of fact and conclusions of law. We remand this application 1

so the trial court can either forward its findings and conclusions or complete its evidentiary

investigation and make findings and conclusions. 

This application will be held in abeyance. If the trial court made findings and conclusions that

inadvertently were not forwarded with the record, they shall be forwarded to this Court within 30

days of the date of this order. If the trial court has not yet made findings and conclusions, the issues

shall be resolved within 90 days of this order. A supplemental transcript containing all affidavits and

interrogatories or the transcription of the court reporter’s notes from any hearing or deposition, along

with the trial court’s supplemental findings of fact and conclusions of law, shall be forwarded to this

Court within 120 days of the date of this order. Any extensions of time must be requested by the trial

court and shall be obtained from this Court. 

Filed: April 17, 2019

Do not publish

 In a motion filed in the trial court, Applicant stated that the trial court made findings

1

and conclusions on November 7, 2017, and recommended that relief be denied.
<TABLE> <S> <C>


<ARTICLE>                                            9
<MULTIPLIER>                                         1
       
<S>                                            <C>
<PERIOD-TYPE>                                     YEAR
<FISCAL-YEAR-END>                          SEP-30-1997 
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                         500,455
<INT-BEARING-DEPOSITS>                       1,590,529
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 92,614,488
<INVESTMENTS-CARRYING>                      29,714,953
<INVESTMENTS-MARKET>                        29,394,100
<LOANS>                                     97,244,031
<ALLOWANCE>                                   (332,000)
<TOTAL-ASSETS>                             231,109,220
<DEPOSITS>                                 125,741,001
<SHORT-TERM>                                18,500,000
<LIABILITIES-OTHER>                          2,202,115
<LONG-TERM>                                 38,000,000
<PREFERRED-MANDATORY>                           39,675
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  45,899,288
<TOTAL-LIABILITIES-AND-EQUITY>             231,109,220
<INTEREST-LOAN>                              7,641,587
<INTEREST-INVEST>                            8,852,278
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                            16,493,865
<INTEREST-DEPOSIT>                           6,176,720
<INTEREST-EXPENSE>                           9,822,725
<INTEREST-INCOME-NET>                        6,671,140
<LOAN-LOSSES>                                   36,618
<SECURITIES-GAINS>                             139,718
<EXPENSE-OTHER>                              4,816,351
<INCOME-PRETAX>                              2,085,246
<INCOME-PRE-EXTRAORDINARY>                   1,745,447
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,745,447
<EPS-PRIMARY>                                      .53
<EPS-DILUTED>                                      .53
<YIELD-ACTUAL>                                    2.98
<LOANS-NON>                                    197,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               345,000
<CHARGE-OFFS>                                   49,618
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                              332,000
<ALLOWANCE-DOMESTIC>                           332,000
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        


</TABLE>
# C_2015007EN.01005901.xml

| 12.1.2015 | EN | Official Journal of the European Union | C 7/59 |
| --- | --- | --- | --- |

12.1.2015

EN

Official Journal of the European Union

C 7/59

---

Action brought on 27 October 2014 — ZZ v Committee of the Regions

(Case F-123/14)

(2015/C 007/75)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: J.-N. Louis, R. Metz and D. Verbeke, lawyers)

Applicant:

Defendant: Committee of the Regions

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Application for annulment of the decision of the Committee of the Regions to apply a solidarity levy from 1 January 2014 to the applicant’s remuneration and not to adjust his remuneration in respect of the period from 1 January 2014 to 30 June 2015.

Form of order sought

Form of order sought

The applicant claims that the Tribunal should:

| — | Declare that Regulation No 1023/2013 is inapplicable in so far as it provides for the suspension from 1 July 2013 to 30 June 2015 of the method of adjustment of remunerations fixed in Article XI of the Staff Regulations, while reintroducing, in respect of the same period, a ‘solidarity’ levy of 6 %; |
| --- | --- |

—

Declare that Regulation No 1023/2013 is inapplicable in so far as it provides for the suspension from 1 July 2013 to 30 June 2015 of the method of adjustment of remunerations fixed in Article XI of the Staff Regulations, while reintroducing, in respect of the same period, a ‘solidarity’ levy of 6 %;

| — | As a result, annul the contested decision; |
| --- | --- |

—

As a result, annul the contested decision;

| — | Order the Committee of the Regions to pay the costs. |
| --- | --- |

—

Order the Committee of the Regions to pay the costs.

---
§ 522.1870 Praziquantel. ( a ) *Specifications.* Each milliliter (mL) of solution contains 56.8 milligrams of praziquantel.
( b ) *Sponsors.* See Nos. 058198 and 061133 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Administer by subcutaneous or intramuscular injection for dogs and puppies 5 pounds (lb) and under, 0.3 mL; for 6 to 10 lb, 0.5 mL; for 11 to 25 lb, 1.0 mL; if over 25 lb, 0.2 mL/5 lb body weight to a maximum of 3 mL.
( ii ) *Indications for use.* For removal of canine cestodes *Dipylidium caninum, Taenia pisiformis,* and *Echinococcus granulosus,* and removal and control of canine cestode *Echinococcus multilocularis.*
( iii ) *Limitations.* Federal law restricts the drug to use by or on the order of a licensed veterinarian.
( 2 ) *Cats* — ( i ) *Amount.* Administer by subcutaneous or intramuscular injection for cats and kittens under 5 lb, 0.2 mL; 5 to 10 lb, 0.4 mL; 11 lb and over, 0.6 mL maximum.
( ii ) *Indications for use.* For removal of feline cestodes *Dipylidium caninum* and *Taenia taeniaeformis.*
( iii ) *Limitations.* Federal law restricts the drug to use by or on the order of a licensed veterinarian.
[46 FR 10464, Feb. 3, 1981, as amended at 47 FR 6617, Feb. 16, 1982; 58 FR 42853, Aug. 12, 1993; 67 FR 79853, Dec. 31, 2002; 78 FR 17868, Mar. 25, 2013; 81 FR 67151, Sept. 30, 2016; 84 FR 8974, Mar. 13, 2019; 86 FR 14820, Mar. 19, 2021]
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1160 Bicarbonate/carbon dioxide test system. ( a ) *Identification.* A bicarbonate/carbon dioxide test system is a device intended to measure bicarbonate/carbon dioxide in plasma, serum, and whole blood. Bicarbonate/carbon dioxide measurements are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance.
( b ) *Classification.* Class II.
Materials Not Included in

Airworthiness Directive (AD) Docket

Docket Number: FAA- 2012-1039

Directorate Identifier: 2011NM275AD

A320-53-1245 --- 3/2/11

Name/Description of Item(s) Not Included in FDMS Docket and Maintained in the 

Supplemental AD Docket

MAY BE VIEWED AT: Federal Aviation Administration

Transport Airplane Directorate

Rules Docket

1601 Lind Ave. SW.,

Renton, WA 98057

425.227.1221

DURING THE HOURS OF: 9 a.m. and 3 p.m., Monday through Friday,

except Federal holidays.

Form Date: 03/05/2008
Exhibit 10.1


 










January 9, 2016







Freedom Mortgage Corporation


907 Pleasant Valley Ave., Suite 3


Mount Laurel, New Jersey 08054







Re: Letter Agreement Dated November 1, 2016, between Cherry Hill Mortgage Investment Corporation    and Freedom Mortgage Corporation








 


Ladies and Gentlemen:







Reference is made to the above-reference agreement (the “Agreement”) regarding the sale of the Excess MSRs and the timing of yield maintenance payments. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement.







Buyer and Seller agree to amend  the Agreement to provide that the yield maintenance payments will be made monthly, rather than quarterly. Accordingly, the Agreement is hereby amended  by deleting paragraph 4 thereof in its entirety and replacing it with the following:







“Buyer shall make yield maintenance payments monthly in an amount equal to two hundred and fifty thousand dollars ($250,000) on the first day of each month, commencing December 1, 2016. If any such date is not a business day, such payment shall be made on the first succeeding business day thereafter. Each such payment shall be made in immediately available funds to the account designated by Seller.”







If you are in agreement with the above, please execute this letter in the space below and return a complete copy to the undersigned whereupon this letter shall constitute a binding agreement between us.







	 	 	
Very truly yours,


	 	 	 
	 	 	
CHERRY HILL MORTGAGE INVESTMENT CORPORATION


	 	 	 
	 	 	
By: /s/ Martin Levine                             


	 	 	
Martin Levine, CFO


	
AGREED TO:

	 	 
	 	 	 
	
FREEDOM MORTGAGE CORPORATION

	 	 
	 	 	 
	
By: /s/ Stanley C. Middleman                        

	 	 
	
Stanley, C. Middleman, President
§ 74.2322 D&C Red No. 22. ( a ) *Identity and specifications.* The color additive D&C Red No. 22 shall conform in identity and specifications to the requirements of § 74.1322(a)(1) and (b).
( b ) *Uses and restrictions.* The color additive D&C Red No. 22 may be safely used for coloring cosmetics generally in amounts consistent with current good manufacturing practice.
( c ) *Labeling requirements.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Certification.* All batches of D&C Red No. 22 shall be certified in accordance with regulations in part 80 of this chapter.
[47 FR 53846, Nov. 30, 1982]
§ 660.51 Processing. ( a ) *Processing method.* ( 1 ) The processing method shall be one that has been shown to yield consistently a specific, potent final product, free of properties that would adversely affect the product for its intended use throughout its dating period.
( 2 ) Anti-IgG, -C3d (polyspecific) reagents and anti-IgG products may be colored green.
( 3 ) Only that material which has been fully processed, thoroughly mixed in a single vessel, and filtered shall constitute a lot. Each lot shall be identified by a lot number.
( 4 ) A lot may be subdivided into sublots which shall be identified by the lot number to which has been added a distinctive prefix or suffix. If lots are to be subdivided, the manufacturer shall include this information in the license application . The manufacturer shall describe the test specifications to verify that each sublot is identical to other sublots of the lot.
( b ) *Final containers and dropper assemblies.* ( 1 ) Final containers and dropper assemblies shall be clean.
( 2 ) Final containers and dropper pipettes shall be colorless and sufficiently transparent to permit observation of the contents for presence of particulate matter or increased turbidity.
( c ) *Date of manufacture.* The date of manufacture shall be the date the manufacturer begins the last entire group of potency tests.
[50 FR 5579, Feb. 11, 1985, as amended at 50 FR 16474, Apr. 26, 1985; 65 FR 77499, Dec. 12, 2000; 67 FR 9587, Mar. 4, 2002]
<PAGE>   1

                                                                     EXHIBIT 5.1


                         Opinion and Consent of Counsel

                                 August 31, 1999



Western Wireless Corporation
3650 131st Avenue S.E.
Bellevue, Washington 98006

     Re: Registration Statement on Form S-8 of Western Wireless Corporation

Ladies and Gentlemen:

     We have acted as counsel to Western Wireless Corporation (the "Company") in
connection with the filing of the above-referenced Registration Statement (the
"Registration Statement") relating to the registration of shares (the "Shares")
of Common Stock, no par value per share, of the Company that may be issued
pursuant to the Western Wireless Corporation 1994 Management Incentive Stock
Option Plan (the "Plan").

     In connection therewith, we have reviewed the Company's Articles of
Incorporation, Bylaws and minutes of appropriate meetings, and we are familiar
with the proceedings to date with respect to the Plan and the proposed issuance
and sale of the Shares and have examined such records, documents and questions
of law, and have satisfied ourselves as to such matters of fact, as we have
considered relevant and necessary as a basis for this opinion.

     Based on the foregoing, it is our opinion that:

     1. The Company is duly incorporated and validly existing under the laws of
the State of Washington.

     2. The Shares, as and when acquired in accordance with the terms and
conditions of the Plan, will be legally issued, fully paid and non-assessable
under the Washington Business Corporation Act when certificates representing the
Shares shall have been duly executed, countersigned and registered and duly
delivered to the purchasers thereof against payment of the agreed consideration
therefor.

     We do not find it necessary for the purposes of this opinion to cover, and
accordingly we express no opinion as to, the application of the securities or
blue sky laws of the various states to the sale of the Shares.


<PAGE>   2




     We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement and to all references to our firm included in or made a
part of the Registration Statement.

                                     Very truly yours,

                                     PRESTON GATES & ELLIS LLP

                                     By       /s/ Gary J. Kocher
                                              Gary J. Kocher
- fplr2256-1
- fplr2256-2
- fplr2256-3
- fplr2256-4
- fplr2256-5
- fplr2256-6
- fplr2256-7
- fplr2256-8
- fplr2256-9
- fplr2256-10
- fplr2256-11
**EXHIBIT 21**
The active subsidiaries of Day International Group, Inc. are listed below, do business under thename under which they are organized, and are included in the consolidated financial statements ofthe Company. The names, jurisdiction of incorporation of such subsidiaries, and percentage ofvoting securities owned by the Company are set forth below.       **Jurisdiction in**    **Which** **Percentage of Voting****Name of Subsidiary** **Incorporated** **Securities owned**Day International, Inc. Delaware 100%Varn International, Inc. Delaware 100% (1)Day International Finance, Inc. Delaware 100% (1)Network Distribution International Massachusetts 100% (1)Network Distribution International, Inc. Massachusetts 100% (2)Day International (U.K.) Holdings Limited United Kingdom 100% (1)Day International (U.K.), Ltd. United Kingdom 100% (3)Varn Products Co., Ltd. United Kingdom 100% (3)Day International France S.A.R.L France 100% (1)Day International de Mexico S.A. de C.V. Mexico 100% (1)Varn Products Company Pty., Ltd. Australia 100% (1)Varn Pressroom Products Sdn. Bhd. Malaysia 100% (1)Varn International (Canada) Limited Canada 100% (1)R T C do Brasil Ltda. Brazil 55% (1)Day Germany Holdings GmbH Germany 100% (1)Day International Group GmbH Germany 100% (4)Rotec Verwaltungs GmbH Germany 100% (5)Rotec Hulsensysteme GmbH & Co. KG Germany 100% (6)Rotec Czech s.r.o. Czech Republic 85% (7)ATPG Textile Products Group GmbH Germany 100% (4)Day International (BRD) GmbH Germany 100% (4)ZAO Day International Russia 75% (8)
(1)  Subsidiary of Day International, Inc. (2)  Subsidiary of Network Distribution International (3)  Subsidiary of Day International (U.K.) Holdings Limited (4)  Subsidiary of Day Germany Holdings GmbH (5)  Subsidiary of Day International Group GmbH (6)  Subsidiary of Rotec Verwaltungs GmbH (7)  Subsidiary of Rotec Hulsensysteme GmbH Co. & KG (8)  Subsidiary of Day International (BRD) GmbH
76
# C_2014093EN.01002001.xml

| 29.3.2014 | EN | Official Journal of the European Union | C 93/20 |
| --- | --- | --- | --- |

29.3.2014

EN

Official Journal of the European Union

C 93/20

---

Request for a preliminary ruling from the Tribunal Superior de Justicia de la Comunidad Autónoma del País Vasco (Spain) lodged on 27 January 2014 — Subdelegación del Gobierno en Gipuzkoa — Extranjería v Samir Zaizoune

(Case C-38/14)

2014/C 93/32

Language of the case: Spanish

Referring court

Referring court

Tribunal Superior de Justicia de la Comunidad Autónoma del País Vasco

Parties to the main proceedings

Parties to the main proceedings

Appellant: Subdelegación del Gobierno en Gipuzkoa — Extranjería

Appellant:

Other party: Samir Zaizoune

Other party:

Question referred

Question referred

In the light of the principles of sincere cooperation and the effectiveness of directives, must Articles 4(2), 4(3) and 6(1) of Directive 2008/115/EC (1) be interpreted as meaning that they preclude legislation, such as the national legislation at issue in the main proceedings and the case-law which interprets it, pursuant to which the illegal stay of a foreign national may be punishable just by a financial penalty, which, moreover, may not be imposed concurrently with the penalty of removal?

1

---

(1)  Directive 2008/115/EC of the European Parliament and of the Council of 16 December 2008 on common standards and procedures in Member States for returning illegally staying third-country nationals (OJ 2008 L 348, p. 98).

1

---
EXHIBIT 10.8


                                 PROMISSORY NOTE

$20,000.00                        Dallas, Texas                  October 1, 1998

         FOR VALUE  RECEIVED,  Preferred  Voice,  Inc.,  a Delaware  corporation
promises to pay to the order of  Universal  Asset Fund Ltd.,  at P.O.  Box 3444,
Road Town,  Tortola,  British  Virgin  Islands,  or at such other address as the
holder  hereof may  designate,  the  principal  sum of Twenty  Thousand  Dollars
($20,000.00),  together with interest on the unpaid  principal  balance from the
date hereof until this note is paid in full at a rate of 10% per annum.

         Principal and interest  shall be payable in one  installment on October
1, 1999.

         All payments  received shall be applied first to the payment of accrued
interest and then to the payment of principal.

         Maker shall have the right to prepay any and all amounts due  hereunder
without penalty for the privilege of doing so.

         No payment shall be considered in default  unless it is not paid within
ten (10) days after delivery of written notice of nonpayment.

         Holder will have the right at any time to convert this note into shares
of common stock,  $.001 par value per share, of Maker, at the conversion rate of
one share of common  stock for each $.50 of  principal  and  interest due on the
note on the date of conversion.

         In the event  default is made in the  payment of this Note,  the unpaid
balance on this Note shall at once become due and payable,  without  notice,  at
the option of the Holder. Failure to exercise this option shall not constitute a
waiver of the right to declare the entire  principal  due and payable at once at
any subsequent time.

         If, after default,  this Note is placed in the hands of an attorney for
collection,  or if collected  through judicial  proceeding,  Maker shall pay, in
addition to the sums  referred to above,  a reasonable  sum as a  collection  or
attorneys'  fee and all other  costs  incurred  by Holder in  collection  of the
unpaid amounts due hereunder.

         Each maker, surety,  guarantor,  endorser or other party liable for the
payment of this Note, in whole or in part,  hereby expressly waives  presentment
and demand for payment,  notice of intention to accelerate  maturity,  notice of
acceleration of maturity, protest and notice of protest and nonpayment, bringing
of suit and  diligence  in taking any action to collect sums owing  hereon,  and
agree that this Note,  and any payment  hereunder,  may be extended from time to
time without in any way affecting such liability.

MAKER:

Preferred Voice, Inc.



-------------------------
G. Ray Miller
Its: President
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5775 Rheumatoid factor immunological test system. ( a ) *Identification.* A rheumatoid factor immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the rheumatoid factor (antibodies to immunoglobulins) in serum, other body fluids, and tissues. Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis.
( b ) *Classification.* Class II (performance standards).
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack

, Chief Justice

Brian K. Zahra

David F. Viviano

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh

Elizabeth M. Welch

, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

J anuary 22 , 2021 

# Order

Clerk January 2 9 , 2021

156150( 52 )

JOSHUA WADE,

Plaintiff

- Appellant,

SC: 156150

v COA: 330555

Ct of Claims: 15

- 000129

- MZ

UNIVERSITY OF MICHIGAN,

Defendant

- Appellee

.

______________________________________ /

On order of the C hief Justice

, the joint motion of the Fair Housing Center of

Southeast and Mid

- Michigan, the Fair Housing Center of Southwest Michigan, and the

Fair Hou sing Center of West Michigan to file a brief amicus curiae is GRANTED. The

amicus brief submitted on January 22, 2021, is accepted for filing.

.